Literature DB >> 22005255

Respiratory mechanics and lung tissue remodeling in a hepatopulmonary syndrome rat model.

César Augusto Melo-Silva1, Eduardo Gaio, José E Trevizoli, Caio S Souza, Alessandra S Gonçalves, Guilherme C C Sousa, Gustavo Takano, Paulo Tavares, Veronica M Amado.   

Abstract

Intrapulmonary vasodilation is a hallmark of the hepatopulmonary syndrome (HPS). However, its effects on respiratory mechanical properties and lung morphology are unknown. To determine these effects, 28 rats were randomly divided to control and experimental HPS groups (eHPS). The spontaneous breathing pattern, gas exchange, respiratory system mechanical properties, and lung and liver morphology of the rats were evaluated. Tidal volume, minute ventilation and mean inspiratory flow were significantly reduced in the eHPS group. Chest wall pressure dissipation against the resistive and viscoelastic components and elastic elastance were increased in the eHPS group. The lung resistive pressure dissipation was lower but the viscoelastic pressure was higher in the eHPS group. The airway volume proportion of collagen and elastic fibers was increased in the eHPS animals (16% and 51.7%; P<0.05 and P<0.001, respectively). The proportion of collagen volume in the vasculature increased 29% in the eHPS animals (P<0.01). HPS presents with respiratory system mechanical disarray as well as airway and vascular remodeling.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22005255     DOI: 10.1016/j.resp.2011.10.001

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  6 in total

Review 1.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

2.  Fish Oil Nanoemulsion Supplementation Attenuates Bleomycin-Induced Pulmonary Fibrosis BALB/c Mice.

Authors:  Danielle Galdino de Souza; Débora Silva Santos; Karina Smidt Simon; José Athayde Vasconcelos Morais; Luísa Coutinho Coelho; Thyago José Arruda Pacheco; Ricardo Bentes Azevedo; Anamélia Lorenzetti Bocca; César Augusto Melo-Silva; João Paulo Figueiró Longo
Journal:  Nanomaterials (Basel)       Date:  2022-05-14       Impact factor: 5.719

Review 3.  Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.

Authors:  Sarah Raevens; Michael B Fallon
Journal:  Hepatology       Date:  2018-11       Impact factor: 17.425

Review 4.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

5.  Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS).

Authors:  Wenli Yang; Bingqian Hu; Wei Wu; Sachin Batra; Michael R Blackburn; Joseph L Alcorn; Michael B Fallon; Junlan Zhang
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

Review 6.  Hepatopulmonary syndrome.

Authors:  Sarah Raevens; Maxine Boret; Michael B Fallon
Journal:  JHEP Rep       Date:  2022-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.